Quantcast

Latest Dronedarone Stories

2014-05-20 08:32:11

Editor Note: For more information about this release, please scroll to bottom. NEW YORK, May 20, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts'

2012-04-26 23:01:58

On April 15th 2012, the Financial Times reported that Sanofi’s drug Multaq lost reimbursement in France and faced new restrictions in other countries.

2012-02-28 10:35:00

An irregular heartbeat — atrial fibrillation — is a strong predictor of cognitive decline and the loss of independence in daily activities in older people at risk of cardiovascular disease.

2011-06-27 15:00:00

LA JOLLA, Calif., June 27, 2011 /PRNewswire/ -- Celladon Corp., a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, announces that the data from its completed Phase 2 CUPID clinical study of MYDICAR® for the treatment of advanced heart failure is being published today online in Circulation, an American Heart Association journal.

2011-05-23 09:00:00

SEATTLE, Wash., May 23, 2011 /PRNewswire/ -- Celladon Corp., a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, today announced that 18-month data from its Phase 2 CUPID clinical trial of MYDICAR® demonstrated continued improvements in clinical outcomes in advanced heart failure patients treated with the genetically-targeted enzyme replacement therapy.

2011-05-04 19:26:22

Two studies to be presented this week address the often-overlooked costs associated with atrial fibrillation (AFib), the most common form of cardiac arrhythmia.

2011-02-18 08:08:51

Use of an implanted device to monitor the condition of heart failure patients reduces the rate of hospitalization by 39 percent, according to this study.


Word of the Day
swell-mobsman
  • A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.
Use of the word 'swell-mobsman' dates at least to the early 1800s.